Oncopeptides AB (publ) (STO:ONCO)
1.640
-0.051 (-3.02%)
Nov 20, 2026, 5:29 PM CET
Oncopeptides AB Employees
Oncopeptides AB had 71 employees as of September 30, 2026. The number of employees decreased by 4 or 5.33% compared to the same quarter last year. That makes Oncopeptides AB the 33,369th largest employer in the world and 405th in Sweden.
Employees
71
Change (1Y)
-4
Growth (1Y)
-5.33%
Revenue / Employee
1.46M SEK
Profits / Employee
-2.76M SEK
Market Cap
648.27M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 71 | -4 | -5.33% |
| Jun 30, 2026 | 69 | -6 | -8.00% |
| Mar 31, 2026 | 77 | 2 | 2.67% |
| Dec 31, 2025 | 75 | -5 | -6.25% |
| Sep 30, 2025 | 75 | -4 | -5.06% |
| Jun 30, 2025 | 75 | 8 | 11.94% |
| Mar 31, 2025 | 75 | 13 | 20.97% |
| Dec 31, 2024 | 80 | 23 | 40.35% |
| Sep 30, 2024 | 79 | 15 | 23.05% |
| Jun 30, 2024 | 67 | 4 | 6.35% |
| Mar 31, 2024 | 62 | 3 | 5.08% |
| Dec 31, 2023 | 57 | 16 | 39.02% |
| Sep 30, 2023 | 64 | 24 | 60.50% |
| Jun 30, 2023 | 63 | 19 | 43.18% |
| Mar 31, 2023 | 59 | -17 | -22.37% |
| Dec 31, 2022 | 41 | -121 | -74.69% |
| Sep 30, 2022 | 40 | -281 | -87.54% |
| Jun 30, 2022 | 44 | -269 | -85.94% |
| Mar 31, 2022 | 76 | -218 | -74.15% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sprint Bioscience AB | 33 |
| Xspray Pharma AB | 24 |
| Cantargia AB | 22 |
| Corline Biomedical AB | 14 |
| AlzeCure Pharma AB | 10 |
| SynAct Pharma AB | 8 |
| Flerie AB | 8 |
| Isofol Medical AB | 7 |
Oncopeptides AB News
- 17 days ago - Oncopeptides AB Earnings Call Transcript: Q3 2026 - Transcripts
- 17 days ago - Oncopeptides AB Quarterly report: Q3 2026 - Filings
- 17 days ago - Oncopeptides AB Slides: Q3 2026 - Filings
- 5 weeks ago - Oncopeptides AB Transcript: Study update - Transcripts
- 5 weeks ago - Oncopeptides AB Press release: Study update - Filings
- 5 weeks ago - Oncopeptides AB Slides: Study update - Filings
- 2 months ago - Oncopeptides AB Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Oncopeptides AB Quarterly report: Q2 2026 - Filings